Physician profile
Thomas B Bemenderfer
NPI 1891105425
$27,904.67
in general payments reported to CMS, 2019-2025
15 companies · $14K in 2025
The $14K reported for 2025 was more than what 89% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,742 · 2020: $2,489 · 2021: $1,740 · 2022: $3,322 · 2023: $2,512 · 2024: $917 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $3,370 · Travel and Lodging: $3,020 · Education: $9.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,212.50 |
| Food and Beverage | $3,370.31 |
| Travel and Lodging | $3,020.25 |
| Education | $9.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $20,155.31 | 2019-2025 | Inbone, Prophecy, Invision |
| Wright Medical Technology, INC. | $1,655.17 | 2019-2020 | |
| Peerless Surgical INC. | $1,498.32 | 2019 | |
| Crossroads Orthopedics, LLC | $1,226.08 | 2022-2023 | |
| Paragon 28, INC. | $1,073.96 | 2019-2024 | Ttc Nail, Grappler |
| Smith+Nephew, INC. | $795.40 | 2019-2023 | Redapt |
| Exactech, INC. | $573.80 | 2021 | |
| Novastep INC. | $171.02 | 2021 | |
| Zimmer Biomet Holdings, INC. | $164.00 | 2019-2020 | |
| Orthofix Medical, INC. | $148.16 | 2022-2025 | Physio-Stim |
| Linvatec Corporation | $146.87 | 2024 | Linvatec Video Accessories, Biobrace 23mm, Linvatec Arthroscopy |
| Amgen INC. | $121.28 | 2023 | Evenity |
| Nevro Corp. | $91.24 | 2021 | |
| Depuy Synthes Sales INC. | $52.29 | 2019-2023 | Na |
| Kerecis Limited | $31.77 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Bemenderfer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.